OpenAI introduced the Rosalind Academic Plan, a program that offers eligible academic research labs sponsored access to GPT‑Rosalind and the Rosalind Workbench, tools designed for life‑sciences research. The company said the plan aims to help university labs combine scientific expertise with specialized model reasoning across medicinal chemistry, genomics, wet‑lab assistance and related areas.
What the plan provides
According to OpenAI, eligible labs at U.S. universities can receive up to 30 Business Standard seats at $0 per user per month for up to 12 months. The plan includes access to commercially available frontier OpenAI models subject to usage limits, and access to GPT‑Rosalind is available following a trusted‑access approval process. OpenAI noted that research data shared through the Rosalind Academic Plan is not used to train its models by default.
The announcement lists research areas targeted for use of GPT‑Rosalind, including drug and protein design; disease detection and monitoring; vaccines and immune response; genetic and RNA therapies; agriculture and animal health; ecology and conservation; and antimicrobial resistance.
Use cases and safeguards
OpenAI highlighted examples of academic groups already using GPT‑Rosalind. The Zhao Lab at UCSF reported that GPT‑Rosalind helped gather drug physicochemical parameters more quickly, while Dr. Mathieu Bourdenx said GPT models assist literature review and experiment refinement. Dr. Brian Hie of Stanford University and Arc Institute described Rosalind as helping scale discovery and design tasks while providing insights to biological researchers. These statements are presented as the labs’ reported experiences.
Access requires institutional verification and review of the PI or lab lead’s identity, appointment and authority to oversee lab access. OpenAI described ongoing monitoring and safety checks, and said that registered high‑sensitivity use cases receive additional review. The company also clarified that API access is not included in the Rosalind Academic Plan.
PIs and lab leads at eligible organizations without an OpenAI Enterprise agreement are directed to apply through the trusted‑access process; labs at institutions with Enterprise agreements must request GPT‑Rosalind via their university’s Enterprise access path. GPT‑Rosalind access remains subject to approval.
Original source: OpenAI News